Fund moves
76 tracked managers disclosed the same change for Q1 2026. From a 13F filed Jun 9, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded May 20, 2026 · Filed May 21, 2026
A Boston Scientific director paid $100K out of pocket for Boston Scientific shares. 2 other people at Boston Scientific bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$99,987
Shares × reported transaction price
$25K–$100K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
28 days after results of Apr 22, 2026, 70 days before results of Jul 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $56.67 on May 20, 2026, 8% above its 52-week low and 48% below its high, after a 9% drop over the previous 30 trading days
52-week range $52.68 (May 15, 2026) to $108.14 (Sep 8, 2025), 7% of the way up, from 251 adjusted closes. 30 trading days earlier: $62.56 on Apr 8, 2026. Describes the past only, not a forecast
RSI 46, 35% under its 200-day average, 9% under its 50-day average, 48% below the 52-week high, 20-day volatility 41% a year, against the S&P 500: −10 points over 1 month, −33 points over 3 months, −56 points over 6 months
From the adjusted closes up to May 20, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
3 BSX insiders bought within the same week. That happened 5 times before in filings since 2006, most recently Aug 2012. Cheryl Pegus's first open-market purchase of BSX in filings since 2006
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
A securities lawsuit naming the company as a defendant was filed on Mar 5, 2026 in the U.S. District Court, D. Massachusetts. A filing is an allegation, not a finding.
2 such cases were open. In re: Boston Scientific Corporation Securities Litigation, docket 1:26-cv-40075, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −16.4% | +1.4% | −17.8% |
| 30 days | −23.3% | −0.2% | −23.1% |
| 90 days | −14.6% | +2.3% | −16.8% |
| 180 days | −24.5% | −2.1% | −22.4% |
Past results only. Not a forecast.
Fund moves
76 tracked managers disclosed the same change for Q1 2026. From a 13F filed Jun 9, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Congress
Traded May 19 · disclosed 20 days later
3 different filers disclosed BSX within 90 days.
Congress
Traded May 29 · disclosed 10 days later
3 different filers disclosed BSX within 90 days.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.